{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:31:30Z","timestamp":1762075890029,"version":"3.41.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm Gen Sect"],"published-print":{"date-parts":[[1991,9]]},"DOI":"10.1007\/bf02259538","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T00:13:33Z","timestamp":1132704813000},"page":"203-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease"],"prefix":"10.1007","volume":"3","author":[{"given":"P. -A.","family":"L\u00f6schmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. W.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kunow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. -J.","family":"Rettig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"J\u00e4hnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Turski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. D.","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1991,9,1]]},"reference":[{"key":"BF02259538_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.2402638","volume":"249","author":"H Bergman","year":"1990","unstructured":"Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436\u20131438","journal-title":"Science"},{"key":"BF02259538_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870060208","volume":"6","author":"JM Brotchie","year":"1991","unstructured":"Brotchie JM, Mitchell IJ, Sambrook MA, Crossman A (1991) Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Movement Disorders 6: 133\u2013138","journal-title":"Movement Disorders"},{"key":"BF02259538_CR3","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism; selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546\u20134550","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02259538_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF01255820","volume":"77","author":"M Carlsson","year":"1989","unstructured":"Carlsson M, Carlsson A (1989) Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. J Neural Transm 77: 65\u201371","journal-title":"J Neural Transm"},{"key":"BF02259538_CR5","first-page":"947","volume-title":"Handbook of physiology, sect 1. The nervous system II","author":"MB Carpenter","year":"1981","unstructured":"Carpenter MB (1981) Anatomy of the corpus striatum and brain stem integrating systems. In: Brooks VB (ed) Handbook of physiology, sect 1. The nervous system II. American Physiological Society, Bethesda, pp 947\u2013995"},{"key":"BF02259538_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02244093","volume":"102","author":"SP Close","year":"1990","unstructured":"Close SP, Elliot PJ, Hayes AG, Marriott AS (1990) Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease. Psychopharmacology 102: 295\u2013300","journal-title":"Psychopharmacology"},{"key":"BF02259538_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/0028-3908(89)90221-9","volume":"28","author":"AR Crossman","year":"1989","unstructured":"Crossman AR, Peggs D, Boyce S, Luquin MR, Sambrook MA (1989) Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey. Neuropharmacology 28: 1271\u20131273","journal-title":"Neuropharmacology"},{"key":"BF02259538_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","volume":"1","author":"GC Davis","year":"1979","unstructured":"Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249\u2013254","journal-title":"Psychiatry Res"},{"key":"BF02259538_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.1984.tb09689.x","volume":"42","author":"F Fonnum","year":"1984","unstructured":"Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42: 1\u201311","journal-title":"J Neurochem"},{"key":"BF02259538_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","volume":"50","author":"P Jenner","year":"1984","unstructured":"Jenner P, Rupniak NMJ, Rose S, Kelley E, Kilpatrick G, Lees A, Marsden CD (1984) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci Lett 50: 85\u201390","journal-title":"Neurosci Lett"},{"key":"BF02259538_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0166-2236(89)90007-6","volume":"12","author":"T Klockgether","year":"1989","unstructured":"Klockgether T, Turski L (1989) Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci 12: 285\u2013286","journal-title":"Trends Neurosci"},{"key":"BF02259538_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.410280411","volume":"28","author":"T Klockgether","year":"1990","unstructured":"Klockgether T, Turski L (1990) NMDA antagonists potentiate antiparkinsonian actions of L-Dopa in monoamine-depleted rats. Ann Neurol 28: 539\u2013546","journal-title":"Ann Neurol"},{"key":"BF02259538_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-94-011-2262-7_30","volume-title":"Amino acids: chemistry, biology and medicine","author":"T Klockgether","year":"1990","unstructured":"Klockgether T, Turski L, L\u00f6schmann P-A, Wachtel H (1990) N-Methyl-D-aspartate antagonists stimulate locomotor activity in monoamine depleted rats: implications for therapy of Parkinson's disease. In: Lubec G, Rosenthal GA (eds) Amino acids: chemistry, biology and medicine. ESCOM Science Publishers B.V, Leiden, pp 269\u2013275"},{"key":"BF02259538_CR14","volume-title":"The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem","author":"JFR K\u00f6nig","year":"1963","unstructured":"K\u00f6nig JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem. William and Wilkins, Baltimore"},{"key":"BF02259538_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0014-2999(89)90384-1","volume":"166","author":"J Kornhuber","year":"1989","unstructured":"Kornhuber J, Bormann J, Retz W, H\u00fcbers M, Riederer P (1989) Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166: 589\u2013590","journal-title":"Eur J Pharmacol"},{"key":"BF02259538_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0922-4106(91)90113-V","volume":"206","author":"J Kornhuber","year":"1991","unstructured":"Kornhuber J, Bormann J, H\u00fcbers M, Rusche E, Riederer P (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Eur J Pharmacol (Mol Pharmacol Sect) 206: 297\u2013300","journal-title":"Eur J Pharmacol (Mol Pharmacol Sect)"},{"key":"BF02259538_CR17","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1126\/science.6332378","volume":"225","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard B, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidineanalog synthesis. Science 225: 1480\u20131482","journal-title":"Science"},{"key":"BF02259538_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0014-2999(89)90348-8","volume":"166","author":"P-A L\u00f6schmann","year":"1989","unstructured":"L\u00f6schmann P-A, Chong PN, Nomoto M, Tepper PG, Horn AS, Jenner P, Marsden CD (1989) Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437. Eur J Pharmacol 166: 373\u2013380","journal-title":"Eur J Pharmacol"},{"key":"BF02259538_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","volume":"i","author":"CD Marsden","year":"1976","unstructured":"Marsden CD, Parkes JD (1976) On-off effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet i: 292\u2013296","journal-title":"Lancet"},{"key":"BF02259538_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0014-2999(90)90066-F","volume":"182","author":"M Morelli","year":"1990","unstructured":"Morelli M, Di Chiara G (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182: 611\u2013612","journal-title":"Eur J Pharmacol"},{"key":"BF02259538_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1126\/science.164.3880.719","volume":"164","author":"JW Olney","year":"1969","unstructured":"Olney JW (1969) Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 164: 719\u2013721","journal-title":"Science"},{"key":"BF02259538_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0014-2999(87)90123-3","volume":"142","author":"JW Olney","year":"1987","unstructured":"Olney JW, Price MT, Labruyere J, Salles KS, Frierdich G, Mueller M, Silverman E (1987) Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol 142: 319\u2013320","journal-title":"Eur J Pharmacol"},{"key":"BF02259538_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ddr.430170406","volume":"17","author":"JW Olney","year":"1989","unstructured":"Olney JW (1989) Excitotoxicity and N-methyl-D-aspartate receptors. Drug Dev Res 17: 299\u2013319","journal-title":"Drug Dev Res"},{"key":"BF02259538_CR24","unstructured":"Riederer R, Kornhuber J, Gerlach M, Danielczyk W, Youdim MBH (1991) Glutamatergic-dopaminergic imbalance in Parkinson's disease and paranoid hallucinatory psychosis. In: Rinne UK, Nagatsu T, Horowski R (eds) Proceedings International Workshop Parkinson's Disease: from Basic Research and Early Diagnosis to Long-Term Treatment. Medicom Europe BV, Bussum The Netherlands (in press)"},{"key":"BF02259538_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1126\/science.2154034","volume":"247","author":"MJ Sheardown","year":"1990","unstructured":"Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honor\u00e9 T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benz(F)quinoxaline: a neuroprotectant for cerebral ischaemia. Science 247: 571\u2013574","journal-title":"Science"},{"key":"BF02259538_CR26","first-page":"191","volume-title":"Current problems in epilepsy 4. New anticonvulsant drugs","author":"AS Troupin","year":"1986","unstructured":"Troupin AS, Mendius JR, Cheng F (1986) MK 801. In: Meldrum BS, Potter RJ (eds) Current problems in epilepsy 4. New anticonvulsant drugs. John Libbey, London, pp 191\u2013201"},{"key":"BF02259538_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/349414a0","volume":"349","author":"L Turski","year":"1991","unstructured":"Turski L, Bressler K, Rettig K-J, L\u00f6schmann P-A, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349: 414\u2013418","journal-title":"Nature"},{"key":"BF02259538_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt U (1968) 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5: 107\u2013110","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Neural Transmission - Parkinson's Disease and Dementia Section"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02259538\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:46:56Z","timestamp":1750819616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02259538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["BF02259538"],"URL":"https:\/\/doi.org\/10.1007\/bf02259538","relation":{},"ISSN":["0936-3076"],"issn-type":[{"type":"print","value":"0936-3076"}],"subject":[],"published":{"date-parts":[[1991,9]]},"assertion":[{"value":"23 May 1991","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 1991","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 1991","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}